跳至主要内容
临床试验/NCT04245098
NCT04245098Unknown不适用

Carpal Tunnel Syndrome and Amyloidosis

Corporacion Parc Tauli2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2020年1月8日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
100
试验地点
2
主要终点
Number of participants with amyloid deposits in patients undergoing carpal tunnel surgery

研究概览

简要总结

Carpal tunnel syndrome has been suggested to be an early sign of amyloidosi. The investigators will evaluate tissue samples obtained from patients undergoing carpal tunnel release surgery for amyloid.

详细描述

Carpal tunnel syndrome (CTS) can be caused by the deposition and accumulation of misfolded proteins called amyloid and is often an early manifestation of systemic amyloidosis.

Patients with cardiac amyloidosis often have carpal tunnel syndrome that precedes cardiac manifestations by several years, and many patients will have undergone surgery for idiopathic carpal tunnel syndrome since the protein also deposits in the transversal carpal ligament of the hand.

The investigators sought to identify the prevalence and type of amyloid deposits in patients undergoing carpal tunnel surgery and evaluate for cardiac involvement

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients undergoing carpal tunnel syndrome surgery

排除标准

  • 未提供

结局指标

主要结局

Number of participants with amyloid deposits in patients undergoing carpal tunnel surgery

时间窗: 2 years

Prevalence of amyloid deposits in biopsy in patients undergoing carpal tunnel syndrome surgery

次要结局

  • Number of participants with cardiac involvement in echocardiogram(2 years)

研究者

发起方
Corporacion Parc Tauli
申办方类型
Other
责任方
Principal Investigator
主要研究者

Maria del Carmen Navarro-Saez

Principal Investigator

Corporacion Parc Tauli

研究点 (2)

Loading locations...

相似试验